Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $161,685 - $187,202
-1,671 Reduced 38.42%
2,678 $259,000
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $101,865 - $123,123
-998 Reduced 18.66%
4,349 $473,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $609,664 - $743,446
5,347 New
5,347 $633,000
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $250,510 - $294,887
-2,368 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $257,733 - $303,648
2,368 New
2,368 $284,000
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $301,035 - $328,042
-2,867 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $262,731 - $319,068
2,867 New
2,867 $312,000
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $741,276 - $1.08 Million
-11,800 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $926,418 - $1.03 Million
11,800 New
11,800 $1.03 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $223B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.